Edition:
United States

Cytokinetics Inc (CYTK.OQ)

CYTK.OQ on NASDAQ Stock Exchange Global Select Market

8.90USD
4:00pm EDT
Change (% chg)

$-0.40 (-4.30%)
Prev Close
$9.30
Open
$9.20
Day's High
$9.20
Day's Low
$8.85
Volume
40,895
Avg. Vol
107,457
52-wk High
$15.95
52-wk Low
$6.80

Chart for

About

Cytokinetics, Incorporated is a late-stage biopharmaceutical company. The Company is focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. It is focused on the discovery and development... (more)

Overall

Beta: 1.52
Market Cap(Mil.): $504.04
Shares Outstanding(Mil.): 54.20
Dividend: --
Yield (%): --

Financials

  CYTK.OQ Industry Sector
P/E (TTM): -- 214.97 33.20
EPS (TTM): -2.59 -- --
ROI: -56.26 -3.79 13.23
ROE: -135.61 -5.32 15.28

BRIEF-Cytokinetics And Cure SMA Renew And Expand Partnership To Advance Education And Awareness Of SMA

* CYTOKINETICS AND CURE SMA RENEW AND EXPAND PARTNERSHIP TO ADVANCE EDUCATION AND AWARENESS OF SMA

May 17 2018

BRIEF-Cytokinetics Reports Q1 Loss Per Share Of $0.56

* CYTOKINETICS, INC. REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

Apr 26 2018

BRIEF-Cytokinetics Qtrly Net Loss Per Share $0.75

* CYTOKINETICS, INC. REPORTS FOURTH QUARTER 2017 FINANCIAL RESULTS

Feb 15 2018

Earnings vs. Estimates